US Broker Ratings

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Navigating High Expectations with Cutting-Edge Medical Innovations

Pulse Biosciences, Inc. (NASDAQ: PLSE), a promising player in the healthcare sector, is making waves with its pioneering bioelectric medicine technologies. Despite its relatively young establishment..

Certara, Inc. (CERT) Stock Analysis: Navigating the Healthcare Sector with Technology-Driven Solutions

Investors eyeing opportunities in the healthcare sector might find Certara, Inc. (NASDAQ: CERT) a company worth examining. As a provider of innovative technology-driven services and software..

CG Oncology, Inc. (CGON) Stock Analysis: Potential 31.15% Upside in Biotech Sector

Investors eyeing the biotechnology sector should pay close attention to CG Oncology, Inc. (NASDAQ: CGON), a prominent player in the healthcare industry. With a market capitalization..

Belite Bio, Inc (BLTE) Investor Outlook: Unveiling a 35.99% Potential Upside in Biotech Innovation

Belite Bio, Inc (BLTE), a promising player in the biotechnology sector, has captured investor attention with its cutting-edge research and development focus. With a robust market..

Innoviva, Inc. (INVA) Stock Analysis: Biotech Powerhouse with 70% Upside Potential

Innoviva, Inc. (NASDAQ: INVA), a biopharmaceutical company based in Burlingame, California, is making waves in the biotechnology sector with its promising portfolio and strategic collaborations. With..

LivaNova PLC (LIVN) Stock Analysis: Navigating Growth in Healthcare with a 14.3% Revenue Surge

LivaNova PLC (NASDAQ: LIVN) stands at the forefront of medical innovation, showcasing a promising trajectory within the healthcare sector. With its roots in the United Kingdom,..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Analyst Consensus Points to 36% Upside Potential

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV), a key player in the healthcare sector specializing in drug manufacturing for opioid dependence treatment, has garnered significant investor interest. Headquartered..

AdaptHealth Corp. (AHCO) Stock Analysis: A 30% Upside Beckons for Investors

AdaptHealth Corp. (NASDAQ: AHCO) is capturing the attention of investors with a compelling potential upside of over 30%, according to analyst price targets. Specializing in the..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a Potential 69% Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $3.02 billion, this..

Omnicell, Inc. (OMCL)

⚠️ No article content returned.

..

Schrodinger, Inc. (SDGR) Stock Analysis: Unveiling a 34.63% Potential Upside in the Healthcare Sector

Schrodinger, Inc. (SDGR), a pivotal player in the healthcare sector, stands out with its innovative approach to drug and material discovery through its computational platform. As..

Agios Pharmaceuticals (AGIO) Stock Analysis: High Potential Upside in the Biotech Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent name in the biotechnology sector, offers a compelling investment proposition with its innovative focus on cellular metabolism. With a..

Artivion, Inc. (AORT) Stock Analysis: Exploring a 52.89% Potential Upside in the Medical Device Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention due to its notable potential upside. With..

Concentra Group Holdings Parent (CON) Stock Analysis: Robust Growth and Strong Buy Ratings Fuel Investor Optimism

Concentra Group Holdings Parent, Inc. (CON), a key player in the healthcare sector, operates at the intersection of medical care facilities and occupational health services in..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Biotechnology Innovator with 51% Potential Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is making waves in the biotechnology sector, capturing the attention of investors with its promising therapeutic pipeline and robust analyst ratings...

PACS Group, Inc. (PACS) Stock Analysis: Healthcare Giant with 18.35% Upside Potential

PACS Group, Inc. (PACS) stands out as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a robust market capitalization..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A Biotech with 153% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA) is gaining attention from investors with its impressive potential upside of 153.76%, according to analyst ratings. This clinical-stage biotechnology company, headquartered..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Giant with 29% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK), a cutting-edge biopharmaceutical firm, is capturing significant attention in the healthcare sector. With a market capitalization of $5.49 billion, this..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Stable Outlook Amidst Consistent Valuation

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) presents an intriguing opportunity for investors navigating the biotechnology sector, known for its high-risk, high-reward dynamics. With a market capitalization of..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Promising 29.99% Upside in Biotech Innovation

Investors eyeing opportunities in the biotechnology sector should pay close attention to Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canada-based company operating at the cutting edge of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds